De novo deletion of chromosome 11q12.3 in monozygotic twins affected by Poland Syndrome by Carlotta Maria Vaccari et al.
Vaccari et al. BMC Medical Genetics 2014, 15:63
http://www.biomedcentral.com/1471-2350/15/63CASE REPORT Open AccessDe novo deletion of chromosome 11q12.3 in
monozygotic twins affected by Poland Syndrome
Carlotta Maria Vaccari1†, Maria Victoria Romanini2†, Ilaria Musante1, Elisa Tassano3, Stefania Gimelli4,
Maria Teresa Divizia3, Michele Torre5, Carmen Gloria Morovic6, Margherita Lerone3, Roberto Ravazzolo1,3,7
and Aldamaria Puliti1,3,7*Abstract
Background: Poland Syndrome (PS) is a rare disorder characterized by hypoplasia/aplasia of the pectoralis major
muscle, variably associated with thoracic and upper limb anomalies. Familial recurrence has been reported
indicating that PS could have a genetic basis, though the genetic mechanisms underlying PS development are still
unknown.
Case presentation: Here we describe a couple of monozygotic (MZ) twin girls, both presenting with Poland
Syndrome. They carry a de novo heterozygous 126 Kbp deletion at chromosome 11q12.3 involving 5 genes, four of
which, namely HRASLS5, RARRES3, HRASLS2, and PLA2G16, encode proteins that regulate cellular growth,
differentiation, and apoptosis, mainly through Ras-mediated signaling pathways.
Conclusions: Phenotype concordance between the monozygotic twin probands provides evidence supporting the
genetic control of PS. As genes controlling cell growth and differentiation may be related to morphological defects
originating during development, we postulate that the observed chromosome deletion could be causative of the
phenotype observed in the twin girls and the deleted genes could play a role in PS development.
Keywords: Chromosome 11q deletion, Congenital abnormalities, Monozygotic twins, Poland syndrome, CNV,
HRASLS5, HRASLS2, RARRES3, PLA2G16Background
Poland Syndrome (PS) (OMIM 173800) is characterized
by hypoplasia/aplasia of the pectoralis major muscle, va-
riably associated with thoracic and upper limb anomalies.
Thoracic anomalies in PS include breast and rib hypopla-
sia/aplasia, sternal anomalies, mammary gland anomalies,
and limited subcutaneous fat. Upper limb anomalies can
be absent or as severe as phocomelia-like anomalies. The
classic hand deformity in PS includes syndactyly and vari-
able degrees of brachydactyly with hypoplasia or aplasia of
the middle phalanges (reviewed in [1,2]). The incidence of
PS was reported to be 1/30,000-32,000 births with higher
prevalence in males and a male to female ratio estimated* Correspondence: apuliti@unige.it
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unless otherwise stated.between 2:1 and 3:1 [3-5]. The pathogenic mechanisms
underlying PS are still unknown. Indeed, the genetic origin
of the disease is still a matter of debate. One hypothesis
states that PS defects could result from a vascular insult
during early embryological stages, which implies that
environmental factors could contribute to PS phenotype
[6,7]. However, though most cases of PS are sporadic,
familial recurrence with higher prevalence in males has
been observed, which suggests a genetic basis of this
congenital anomaly [3]. Different inheritance patterns,
including autosomal recessive, autosomal dominant, and
dominant with incomplete penetrance, have been reported
and, therefore, genetic heterogeneity might be expected
(reviewed in [3]). Impaired development of structures
involved in PS may be hypothesized, suggesting a pa-
thogenic mechanism involving genes regulating cell pro-
liferation and/or differentiation during development. In
agreement with this view, it has been recently proposed
that all forelimb elements, which include skeletal structures,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ding to a unique program [8].
Here we describe a couple of MZ twin girls with PS, in
whom a deletion at chromosome 11q12.3 was identi-
fied by array-comparative genomic hybridization (array-
CGH). The deletion involved 5 genes, namely: HRASLS5,
LGALS12, RARRES3, HRASLS2, and PLA2G16, among
which four are members of the HREV107 type II tumor
suppressor gene family encoding proteins that regulate
cellular growth, differentiation, and apoptosis.
Case presentation
The twin patients are daughters of healthy non-consan-
guineous parents from Santiago, Chile. No exposure to
drugs, alcohol, and infections was reported during preg-
nancy; the mother was hospitalized three times for threat-
ened abortion. The patients were born full term after
spontaneous delivery. Birth weight was respectively
2.500 kg (first twin) (5th centile) and 2.000 kg (second
twin) (<3rd centile), length was 45 cm (first twin) (3rd
centile) and 40 cm (second twin) (<3rd centile). Both
twins were kept in the neonatal unit because of low birth
weight. The first twin had a normal neonatal period, while
the second showed severe asphyxia at birth. Psychomotor
development and growth were normal in both twins. The
parents reported that the toracic anomaly was well ob-
servable in both girls since the age of 10 years. At the age
of four years, the first twin underwent surgery because of
a thyroglossal duct cyst that, to the best of our knowledge,
has never been previously reported in PS patients. At
twelve years, she presented mild scoliosis withoutFigure 1 Chest images from the twin girls. A and C) First twin. B and D
chest wall indicating pectoral muscle hypoplasia, cranially located nipple, a
before surgery. C and D) Slight asymmetry and pectoral muscle hypoplasia
after surgery.indication for surgical intervention. The second twin had
severe congenital scoliosis, due to multiple vertebral mal-
formations (T4 hemivertebra and T5-T6 butterfly verte-
brae), treated surgically when she was thirteen years old.
Vertebral anomalies, although not common in PS, have
already been reported in some cases [9] and were also
present in another patient of our “independent PS control
group” (see below). At 13 years, the twin girls were admit-
ted to the Luis Calvo Mackenna Hospital (Santiago, Chile)
because of breast asymmetry. Pectoral muscle, breast, and
mild axillary fold hypoplasia on the right side was clini-
cally observable in both patients, more evident in the first
twin. Ultrasound examination revealed, in both patients,
an important breast and pectoralis major muscle hypopla-
sia on the right side, thus confirming the diagnosis of PS.
At that time, both twin girls were referred for genetic
counseling to the Genetic Unit at Luis Calvo Mackenna
Hospital. The clinical geneticist did not observe any ad-
ditional associated dysmorphic features, normally present
in other disorders similar to PS, as anomalies of hair,
teeth, nails, skin, vision, hearing, or neurologic aspects.
Therefore, other associated malformations and syndromes
were excluded in both patients.
At the age of 19 years, the first twin was 1.59 m in
height (25th centile), 52.3 Kg in weight (25th-50th centile);
the second twin was 1.53 m in height (5th centile), 46.7 Kg
in weight (5th-10th centile).
The thoracic anomaly was surgically treated in both
girls at 17 years of age according to already established
protocols [10] (Figure 1). The preoperative evaluation in-
cluded contralateral pectoral and breast measurements) Second twin. A and B) Breast asymmetry, depression of the anterior
nd hypoplastic areola are visible on the right side of both twin girls
are still perceivable, more evident in the first twin (left), two years
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implant, i.e., best reproducing the normal side of the pa-
tient in size, volume, and shape. Indeed, both twin girls
underwent echocardiographic and abdominal ultrasono-
graphic examinations which excluded the presence of any
congenital heart and abdominal abnormalities. X-ray exa-
mination excluded the presence of skeletal anomalies,
other than the vertebral anomalies of the second twin,
and/or skeletal dysplasia reminiscent of other disorders. In
the second twin, slight hypoplasia of the right hand was
observable (Figure 2). Hand length, measured from the tip
of the distal phalanx of the middle finger to the distal
crease of the wrist with the hand in the neutral flexion/ex-
tension pose, was 17.7 cm for the left hand and 16.8 cm
for the right hand. The first twin had symmetric hands
(18.3 cm hand length). Neither patients exhibited any dys-
morphic hand anomalies (Figure 2). In parents and sib-
lings (one sister and one brother, both younger than the
twin girls), PS was excluded on the basis of clinical
evaluation.
A cohort of additional 30 unrelated sporadic PS patients
(19 males and 11 females), defined as “independent PS
control group”, was included in this study for further
molecular investigations. Seventeen patients presented
right-sided PS (9 males and 8 females). Twelve cases had
isolated pectoral muscle hypoplasia/aplasia. Eighteen pa-
tients presented with various associated skeletal defects,
namely: pectus excavatum (n = 1); rib anomalies (n = 3);
vertebral defects (n = 1); craniosynostosis (n = 1); upper
limb anomalies (n = 14).Methods
Genotyping
To investigate the twins’ zygosity, microsatellite analysis was
performed on genomic DNA extracted from each twin’s
blood, using 9 short tandem repeat (STR) loci (D3S1358,
vWA, FGA, TH01, TPOX, CSF1PO, D5S818, D13S317, and
D7S820) and the Amelogenin locus (AmpFLSTR® Profiler®
PCR Amplification Kit, Life Technologies, Foster City, CA,
USA).Figure 2 Hands of the twin girls at the age of 19 years. Hand anomalie
B) Picture of the second twin’s hands showing slight hypoplasia of the righArray comparative genomic hybridization (Array-CGH)
DNA from blood lymphocytes was obtained from twins,
healthy parents, and siblings. The array-CGH analysis
was performed using Human Genome CGH Microarray
Kit G3 180 (Agilent Technologies, Palo Alto, USA) with
~13 Kbp overall median probe spacing. Labelling and
hybridization were performed following the protocols
provided by the manufacturers. A graphical overview
was obtained using the Agilent Genomic Workbench
Lite Edition Software 6.5.0.18.
Aberration segments were reviewed using GRCh37
(February 2009) hg19 of UCSC Genome Browser [11].
DGV (Database of Genomic Variants) [12], DECIPHER
Database [13], and ISCA Consortium database [14] were
also used.
Validation of copy number variations (CNVs)
Array-CGH results were validated by loss of heterozy-
gosity (LOH) analysis and real-time PCR (qPCR). For
LOH analysis, DNA from probands and their parents was
amplified and sequenced using primers specific for four
SNP markers in the deleted region, namely rs4088473,
rs637122, rs7104097, and rs4088472. For qPCR, DNA
from both twin patients and their parents was analyzed, as
well as DNA from one healthy adult used as control.
Primers were designed to amplify a region encom-
passed by the deletion (specific for the HRASLS5 gene,
chr11:63,241,331-63,241,440), a 5′ flanking region (spe-
cific for SLC22A, chr11:63,144,692-63,144,838), and a 3′
flanking region (specific for PLA2G16, chr11:63,375,848-
63,375,956). A region on chromosome 12 encompassing
the GAPDH gene (NM_002046.3) was used as an internal
control to determine copy number and normalize pri-
mer efficiency (primer sequences are available on re-
quest). qPCR was performed using the iCycler (Biorad,
Hercules, CA) with Sybr Green and the comparative
DDCt method [15].
Sequence variation analyses
All 5 genes, either completely or partially encompassed
by the deletion, were screened in a series of sporadics are not evident in any of the two patients. A) First twin’s hands.
t one.
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LGALS12, RARRES3, HRASLS2, PLA2G16. The entire
coding sequence of these genes and their flanking intronic
regions were amplified by PCR on genomic DNA (primer
sequences are available on request), purified, and then se-
quenced on both strands using BigDye dideoxy-terminator
chemistry on an ABI 3100 DNA sequencer (Applied
Biosystems, Foster City, CA). Amino acid change effects
were predicted with the PolyPhen-2 program [16], and
effects on splicing with the BDGP software (The Berkeley
Drosophila Genome Project) [17,18]. To characterize
regions enriched in functional elements, we performed
comparisons of orthologous genomic DNA sequences
using the GERP (Genomic Evolutionary Rate Profiling)
program [19]. Variant results were reviewed using dbSNP
[20] and NHLBI ESP Exome Variant Server [21].Figure 3 Identification of a de novo chromosome 11q12.3 deletion in M
11 deleted segment. B) qPCR results for a region encompassed by the deletio
gene), and a 3′ flanking region (specific for PLA2G16 gene) obtained in the pro
calculated using the comparative DDCt method. Fold change of about 1 is ex
C) Screenshot of chromosome 11 corresponding to the genomic position (ch
(upper red bar), RefSeq genes, and Copy number variations (based on DGV, fiMolecular study results
The DNA microsatellite analysis demonstrated that the
twin girls are identical. The CGH microarray analysis
showed a heterozygous 126 Kbp interstitial deletion
of chromosome 11q12.3, arr [hg19] 11q12.3(63,216,306-
63,342,369)x1, in both patients (Figure 3A). The array-
CGH analysis showed that the deletion was not present in
the probands’ parents and healthy siblings, which in-
dicated a de novo origin. The patients’ CNV was validated
by qPCR (Figure 3B) and LOH analysis, which also
showed that the deletion occurred on the paternal chro-
mosome. The deletion spans the entire sequence of the
following four genes: HRASLS5, LGALS12, RARRES3,
HRASLS2, and, distally, PLA2G16 in its terminal part
(Figure 3). The coding regions of the 5 genes were se-
quenced to exclude the presence of deleterious and/orZ twins with Poland Syndrome. A) Array-CGH profile of chromosome
n (specific for the HRASLS5 gene), a 5′ flanking region (specific for SLC22A
band and one control individual. The copy number changes were
pected for a diploid sample, and of about 0.5 for a haploid sample.
r11:63,216,306-63,342,369, NCBI build 37). Patient chromosome deletion
ltered to show only deletions) in the studied region.
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of both twins. No identical CNV was found in controls
from the DGV database and in our 200 internal controls
except for a smaller CNV in one control (Figure 3C) and a
partially overlapping CNV in another control encompas-
sing HRASLS5, LGASL12, and RARRES3 genes. Similar
CNVs related to specific disorders or intellectual disability
are not included in the ISCA database. A larger deletion
(about 2.6 Mbp) overlapping the probands’ one in a pa-
tient with intellectual disability and apparently no other
associated anomalies is included in the Decipher database.
No mutations affecting any of the screened genes have
ever been reported associated with any known disorders.
In the independent PS control group, overall 8 va-
riants, distributed among 3 out of the 5 screened genes,
were found (Table 1). Three are missense variants; one
is a synonymous variant, and four are in exon-flanking
intronic sequences; none of these four seemed to alter
gene splicing. All of them were previously reported in
variant databases except for one missense heterozygous
variant affecting HRASLS5 (chr11:63,258,424, C > T;
Arg28Gln, Table 1) in one patient. The genomic pos-
ition of this variant did not seem to be very conserved
(GERP score = −5.14); pathogenicity prediction evalua-
ted by PolyPhen2 suggested a possible damaging effect
(0.897 score). This variant was transmitted to the pa-
tient by his healthy father.Discussion
PS has been hypothesized to have a genetic origin. Here
we describe a couple of MZ twin girls both presenting
with PS. Phenotype concordance in monozygotic twins
affected by a disease is generally accepted as evidence sup-
porting the hypothesis that this disease is under genetic
control. In this view, the fact that both our twin girls
exhibited pectoral muscle hypoplasia might contribute to
support the hypothesis of a genetic control of PS.Table 1 Rare gene variants identified in the “independent PS
Gene Position
(hg19)
Ref Alt MAF Variants
HRASLS5 chr11:63,230,659 G C 0.040 Intron_va
HRASLS5 chr11:63,233,710 A G 0.189 Leu207Le
HRASLS5 chr11:63,256,441 C G 0.207 Ala93Pro
HRASLS5 chr11:63,258,424 C T unknown Arg28Gln
LGALS12 chr11:63,276,480 G A 0.023 Intron_va
LGALS12 chr11:63,277,334 A G 0.009 Ile176Val
LGALS12 chr11:63,278,621 C G 0.333 Intron_va
PLA2G16 chr11:63,381,458 C T 0.072 Intron_va
Variant location is reported using hg19 coordinates. MAF, minor allele frequency ac
in the cohort of 30 patients; GERP, Genomic Evolutionary Rate Profiling; the POLYPH
and probably damaging based on the false discovery rate.Both twins exhibited skeletal anomalies, one of the two
showing a more severe phenotype. Discordance in disease
manifestation between affected monozygotic twins has
already been reported and attributed to different patterns
of X chromosome inactivation, epigenetic mechanisms
involving differences in methylation patterns, somatic
mutations casually occurring during development, or en-
vironmental factors [22-24]. The differences in the pheno-
type of our twin girls could otherwise be related to the
effects of vascular interruptions during their embryonic
life due to thrombosed microvasculature caused by predis-
posing genetic factors, as also recently proposed to explain
the origin of PS in a sporadic case [25].
Notably, PS was previously reported in only one of
two identical twin girls [26], indicating the complexity of
genetic mechanisms underlying PS. Our twin girls share
a heterozygous 126 Kbp interstitial deletion at chromo-
some 11q12.3 spanning 5 genes. This specific deletion,
not known to be associated with any specific genetic dis-
orders, could be considered as a candidate region having
a role in PS development. We investigated the function
and expression of the 5 genes with the aim to explore
their involvement in patients’ clinical manifestations.
All forelimb elements, including skeletal structures,
proximal and distal muscles, and sternum, seem to de-
velop according to a unique program [8]. Thus, all tis-
sues involved in PS could develop under the control of
the same group of genes whose mutations may account
for the various features characterizing the PS phenotype.
According to this hypothesis, we considered as less likely
candidate genes those lacking a clear role in the deve-
lopment of tissues involved in PS, as LGALS12, which
encodes a member of the beta-galactoside-binding lectin
family expressed by adipocytes.
The remaining four genes, namely HRASLS5, RARRES3,
HRASLS2, and PLA2G16, are members of the HREV107
type II tumor suppressor gene family known to regulate
cellular growth, differentiation, and apoptosis, mainlycontrol group”
dbSNP id Freq Pathogenicity
GERP POLYPHEN2 prediction
riant rs2282479 0.017 1.14 Unknown
u rs2275999 0.100 4.16 Unknown
rs940611 0.033 −1.03 Benign (0.000)
unknown 0.017 −5.14 Poss-dam (0.897)
riant rs200256001 0.033 −2.69 Unknown
rs117587231 0.017 4.42 Benign (0.005)
riant rs2239679 0.200 −0.07 Unknown
riant rs61929725 0.150 −5.26 Unknown
cording to the NCBI dbSNP137 database; Freq, frequency of the variant allele
EN2 measures of pathogenicity are: Benign, possibly damaging (Poss-dam),
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ticular, RARRES3, a retinoid-inducible growth regulator,
was shown to reduce the level of activated Ras [28]. HRAS
activation was reported to inhibit skeletal myogenesis by
favoring proliferation of myoblasts and by blocking their
differentiation into muscle cells [29-32]. For these reasons,
one may speculate that, in our patients, the heterozygous
deletion of RARRES3 suppressor gene could have induced
an enhancement of HRAS expression and activity inter-
fering with correct skeletal muscle differentiation.
We searched for mutations in all genes involved in the
deletion in a panel of 30 PS patients. Rare variants with no
clear direct causative effects were found. Only one unre-
ported variant was found in one patient, a missense va-
riant in the HRASLS5 gene (Arg28Gln) transmitted to the
PS patient by his healthy father. Thus, it is reasonable to
exclude a direct causative role in PS of this variant, that
could rather act as a predisposing factor. On the one
hand, absence of mutations in a relatively small cohort of
patients suggests that the analyzed genes are not fre-
quently involved in PS, on the other hand, the question
whether the detected rare variants could exert a modifying
effect on the PS phenotype is still controversial.Conclusions
In conclusion, PS phenotype concordance in our mono-
zygotic twin girls might represent an important evidence
supporting the genetic control of PS. The twin patients
shared a heterozygous chromosome 11q12.3 deletion
including genes (HRASLS5, RARRES3, HRASLS2, and
PLA2G16) involved in cellular growth, differentiation,
and apoptosis through Hras signaling pathways. As PS
may result from impaired development, genes control-
ling cell growth and differentiation may represent good
candidate genes. In this view, we postulate that the dele-
tion of one copy of these genes could be causative of PS
phenotype in the twin girls, although future studies are
warranted to clarify which proportion of PS patients
could be accounted for by mutations in these genes.Consent
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